The Particulars: Few studies have explored outcomes after PCI or CABG among patients with diabetes and coronary artery disease (CAD) who require and receive these revascularization approaches.
Data Breakdown: A comparison of PCI and CABG was conducted in 1,900 patients with diabetes and CAD. Most patients involved in the study had three-vessel disease. Among the findings:
| Outcome |
PCI Recipients |
CABG Recipients |
| All-cause death, nonfatal myocardial infarction, or nonfatal stroke |
26.6% |
18.7% |
| All-cause death |
16.3% |
10.9% |
| Myocardial infarction |
13.9% |
6.0% |
| Stroke |
2.4% |
5.2% |
| Cardiovascular death |
10.9% |
6.8% |
Take Home Pearl: Patients with diabetes and multivessel CAD who are treated with CABG appear to have lower rates of all-cause mortality, nonfatal myocardial infarction, and nonfatal stroke when compared with those who are treated with PCI.
